Search - tctmd.com

Displaying 561 - 580 of 2063

Sort: Relevancy | Date

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Michael O'Riordan

April 11, 2019

Presentation ARCH 2019

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Presenter: David G. Rizik

April 11, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Conference News ACC 2019

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

Yael L. Maxwell

March 28, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News ACC 2019

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Yael L. Maxwell

March 25, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

Advertisement

Cancer Survivors With Heart Failure Respond Well to CRT

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Myocardial Injury Often Miscoded as Type 2 MI

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Time and Money: PCI Public Reporting Requirements Take Their Toll

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content